Department of Metabolism, Endocrinology and Molecular Medicine, Osaka City University Graduate School of Medicine, Asahi-machi, Abeno-ku, Japan.
Biomed Pharmacother. 2010 Feb;64(2):113-7. doi: 10.1016/j.biopha.2009.04.038. Epub 2009 Oct 20.
Measurement of the peak systolic velocity (PSV) in the inferior thyroid artery (ITA) before withdrawal of an anti-thyroid drug (ATD) is useful for predicting relapse of Graves' disease (GD). We further investigated whether the ITA-PSV can be used for prediction of GD relapse after delivery in euthyroid women with GD who stopped ATD administration during mid- to late pregnancy.
ITA-PSV was monitored monthly for three months after delivery in 42 women with GD aged from 24 to 45 years old (mean+/-SE: 34.7+/-0.92 years old) who met the above criteria. To confirm the stability of the measurement, ITA-PSV was also measured monthly in 32 age-matched non-pregnant normal women and for three months after delivery in 10 age-matched women.
ITA-PSV and thyroid volume were higher in women with GD immediately after delivery compared to normal women, but the levels of TSH receptor antibody (TRAb) and thyroid-stimulating antibody (TSAb) did not differ significantly between the two groups. Of the 42 patients, 23 had relapse of GD and the smoker/non-smoker ratio and thyroid volume in these patients immediately after delivery were significantly higher than those in the 19 patients who did not undergo relapse (10/23 vs. 0/19, p<0.0001; 24280.3+/-2280.9 vs. 19670.0+/-2103.7mm(3), p=0.046), while ITA-PSV, TRAb and TSAb did not differ between the two groups of patients. The ITA-PSV ratio was calculated by dividing each value in the follow-up period by that obtained immediately after delivery. A significant increase in the mean ITA-PSV ratio occurred at least one month before the time of relapse (1.00+/-0.00 at -3 months before relapse vs. 1.46+/-0.12 at -1 month, p=0.010; 1.00+/-0.00 at -3 months vs. 1.77+/-0.13 at the time of relapse, p=0.0048). In contrast, there were no significant changes in this ratio during the follow-up period in non-relapse patients.
Monthly measurement of ITA-PSV after delivery in remitted euthyroid women with GD may assist in early prediction of GD relapse.
在停用抗甲状腺药物(ATD)之前测量甲状腺下动脉(ITA)的收缩期峰值速度(PSV),对于预测格雷夫斯病(GD)的复发是有用的。我们进一步研究了在中晚期妊娠期间停止 ATD 治疗的 GD 孕妇中,ITAPSV 是否可用于预测产后甲状腺功能正常的 GD 复发。
我们监测了 42 名年龄在 24 至 45 岁(平均+/-SE:34.7+/-0.92 岁)的 GD 妇女的 ITA-PSV,这些妇女符合上述标准,并在产后三个月内每月监测一次。为了确认测量的稳定性,我们还在 32 名年龄匹配的非妊娠正常女性中每月测量一次 ITA-PSV,并在 10 名年龄匹配的女性中测量产后三个月。
产后即刻,GD 妇女的 ITA-PSV 和甲状腺体积高于正常女性,但两组间 TSH 受体抗体(TRAb)和甲状腺刺激抗体(TSAb)水平无显著差异。在 42 例患者中,23 例 GD 复发,这些患者产后即刻的吸烟/不吸烟比例和甲状腺体积明显高于未复发的 19 例患者(10/23 比 0/19,p<0.0001;24280.3+/-2280.9 比 19670.0+/-2103.7mm(3),p=0.046),而 ITA-PSV、TRAb 和 TSAb 在两组患者之间无差异。通过将随访期间的每个值除以产后即刻的值来计算 ITA-PSV 比值。在复发前至少一个月,平均 ITA-PSV 比值显著增加(复发前-3 个月时为 1.00+/-0.00,复发前-1 个月时为 1.46+/-0.12,p=0.010;复发前-3 个月时为 1.00+/-0.00,复发时为 1.77+/-0.13,p=0.0048)。相比之下,在非复发患者的随访期间,该比值没有显著变化。
在 GD 产后甲状腺功能正常的缓解妇女中,每月测量 ITA-PSV 可能有助于早期预测 GD 复发。